Zejula 00173-0912-13
Generic: Niraparib
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 27, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA214876
Need to source Zejula? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Niraparib Tosylate | 200 mg/1 |
Drug Class
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Selected Package
00173-0912-13Selected30 TABLET, FILM COATED in 1 BOTTLE (0173-0912-13)
Other packages for this product(1)
30 TABLET, FILM COATED in 1 BOTTLE (0173-0912-61)